U-Protein Express BV is a biotechnology startup that was recently acquired by ImmunoPrecise Antibodies Ltd.. This company serves as a dedicated contract research organization (CRO), specializing in the production of recombinant antibodies and proteins. Operating as a subsidiary of ImmunoPrecise Antibodies, U-Protein Express BV possesses extensive experience in the field of recombinant protein production. The company boasts its patented r-PEx transient expression platform, which is based on Human Embryonic Kidney cells (HEK293E) and enables the production of fully post-translational modified mammalian recombinant proteins or recombinant antibodies in a remarkably swift timeframe - 4-6 weeks - with yields ranging from 1 mg to 1 gram. The startup, founded in 2007, is currently seeking a protein scientist proficient in molecular biology, cell culture, and protein purification. For those interested, more information is available at www.u-proteinexpress.com/careers.
There is no investment information
No recent news or press coverage available for U-Protein Express BV.